Emergent Health Corp (EMGE)
Emergent Health Corp. was a healthcare company focused on biotechnology-related products, including regenerative medicine, nutraceuticals, and phytonutritional offerings. Its product line included Vita-Stim, Neuvitale, Hungarest, EmergentO2, and items aimed at reducing facial wrinkles. The company said these products were distributed through health food stores, pharmacies, and other retail channels in the United States and abroad. Incorporated in 2006 and based in King of Prussia, Pennsylvania, Emergent Health Corp. was taken private on August 26, 2014.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-EMGE
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
42.695 K
|
—
|
—
|
—
|
—
|
—
|
—
|